Bank of America Securities Remains a Hold on Zoetis (ZTS)

In a report released on June 5, Michael Ryskin from Bank of America Securities maintained a Hold rating on Zoetis, with a price target of $108.00. The company’s shares closed last Friday at $79.44.

Introducing TipRanks MCP for Agents

• Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
• Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.

Ryskin covers the Healthcare sector, focusing on stocks such as Danaher, Thermo Fisher, and Idexx Laboratories. According to TipRanks, Ryskin has an average return of 1.7% and a 50.12% success rate on recommended stocks.

In addition to Bank of America Securities, Zoetis also received a Hold from Argus Research’s Jasper Hellweg in a report issued on May 26. However, on June 3, William Blair maintained a Buy rating on Zoetis (NYSE: ZTS).

Based on Zoetis’ latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $2.26 billion and a net profit of $601 million. In comparison, last year the company earned a revenue of $2.22 billion and had a net profit of $631 million

Based on the recent corporate insider activity of 47 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ZTS in relation to earlier this year. Last month, Frank Damelio, a Director at ZTS bought 6,650.00 shares for a total of $501,343.50.